Watch the recorded webcast from Egetis’ Capital Markets Day

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment

Upcoming event

Latest presentation

Latest Report

April 26, 2023

Q1 Report 2022

Calendar and upcoming reports

August 22, 2023

Interim report January-June 2023

November 8, 2023

Interim report January-September 2023

Joshua’s Story

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com